Clinical Trial Update: Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sotorasib for KRAS G12C-mutated non-small cell lung cancer in patients who have received prior therapy; the study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• sotorasib (sotorasib)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: KRAS P.G12C, Non Small Cell Lung Cancer | Phase 2 | Status: RECRUITING